Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
Public ClinicalTrials.gov record NCT01447719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT01447719
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Interventions
- florbetapir F 18 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2010
- Primary completion
- Feb 28, 2011
- Completion
- Jun 30, 2011
- Last update posted
- Mar 20, 2025
2010 – 2011
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Sun City | Arizona | 85351 | — |
| Research Site | Little Rock | Arkansas | 72211 | — |
| Research Site | Irvine | California | 92697 | — |
| Research Site | Fort Myers | Florida | 33912 | — |
| Research Site | Miami | Florida | 33137 | — |
| Research Site | Miami Beach | Florida | 33140 | — |
| Research Site | Miami Springs | Florida | 33166 | — |
| Research Site | Orlando | Florida | 32835 | — |
| Research Site | Sarasota | Florida | 34231 | — |
| Research Site | St. Petersburg | Florida | 33709 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Baltimore | Maryland | 21221 | — |
| Research Site | Hattiesburg | Mississippi | 39401 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Albany | New York | 12208 | — |
| Research Site | New Hyde Park | New York | 11040 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Centerville | Ohio | 45459 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Charleston | South Carolina | 29425 | — |
| Research Site | Johnson City | Tennessee | 37614 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01447719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01447719 live on ClinicalTrials.gov.